Highlights Klarsen

Equities

ALKLA

FR0011038348

Market Closed - Euronext Paris Other stock markets 09:05:12 09/05/2024 pm IST			5-day change	1st Jan Change
2.25 ^EUR	-3.43%		-0.88%	-17.28%

15/03	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
2023	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	07/11	MT
Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	27/23/27	CI
Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	23/22/23	MT
Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	06/22/06	MT
Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	06/22/06	CI
Acticor Biotech's Drug Candidate For Stroke Treatment Receives Europe's Priority Medicines Tag	22/22/22	MT
Klarsen Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Acticor Biotech lists on Euronext Growth Paris	04/21/04	AQ
Actiplay : Twitter acquires newsletter startup Revue	26/21/26	RE
Actiplay : Twitter acquires newsletter startup Revue	26/21/26	RE
An unknown buyer acquired minority stake in Groupe Actiplay SA from iXO Private Equity.	04/20/04	CI
Groupe Concoursmania acquired Slix Media.	02/15/02	CI
Groupe Concoursmania completed the acquisition of three games websites from Mastodonte Interactive Inc.	17/15/17	CI
Groupe Concoursmania signed a exclusive agreement in principle to acquire three games websites from Mastodonte Interactive Inc.	20/15/20	CI
Groupe Actiplay SA acquired Telaxo.	14/12/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW